jyongbio.com (MENS): O‘sish sur’atiga tuzatilgan narx-foyda
Jyong Biotech Ltd (MENS) avtomatlashtirilgan bioskrinning va AI modellashtirishidan foydalangan holda, neytral geosiyosiy muhitda o'simliklarga asoslangan farmakologiyani rivojlantirmoqda. GURU.Markets tahlillari ushbu PEG momentum ko'rsatkichini taqdim etadi, bunda parametr 0.00 qiymatida mustahkamlandi. Biznes erkaklar salomatligi segmentiga asoslangan bo'lib, Jyong Biotech Ltd (MENS) muvaffaqiyati patent himoyasi va yangi dori vositalarining klinik sinovlari natijalariga bog'liq.
Jyong Biotech Ltd (MENS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Jyong Biotech Ltd|MENS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati jyongbio.com|MENS - Kompaniya qarzlari|Qarzning balans kapitaliga nisbati Jyong Biotech Corp|MENS - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz Jyong Biotech|Shoshilinch likvidlik jyongbio.com
- foyda va bozor koeffitsiyentlari statistikasi:
MENS - Kompaniyaning sof foydasi|Sof foyda prognozi Jyong Biotech Ltd|MENS - P/E multiplikatori|Forvard narx-foyda multiplikatori Jyong Bio|MENS - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Jyong Biotech Corp|MENS - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Jyong Biotech|MENS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi jyongbio.com|MENS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Jyong Biotech Ltd
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:Jyong Biotech Limited
PEG koeffitsiyenti joriy P/E koeffitsiyentini foyda o'sish sur'ati bilan bog'laydi va qiymat birga solishtirganda past bo'lganda, yuqori kengayish potentsialiga ega bo'lgan past baholangan aktivlarni aniqlaydi. peg_co koeffitsiyentini tahlil qilish orqali investor Jyong Biotech Ltd (MENS) bozor qiymatini kelajakdagi MCS-2 dori vositalari savdosi prizmasidan baholashi hamda fitofarmatsevtikalarni tijoratlashtirishga kiritilgan investitsiyalarning samaradorligini biznesning tiklanish sur'atiga nisbatan aniqlashi mumkin.
Jyong Biotech Ltd kimlar bilan raqobatlashadi
HLN (Haleon PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - O‘sish sur’atiga tuzatilgan narx-foyda|LGND: Narx-foyda va o‘sish multiplikatori|amneal.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PRGO: PEG multiplikatori|Alvotech S.A. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|LQDA (Liquidia Technologies) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Galapagos Corp GLPG|Narxning foydaga va o‘sish sur’atiga nisbati ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Amphastar Pharmaceuticals, Inc. AMPH|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati PCRX (Pacira Pharmaceuticals)|SPRY: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Theravance Corp|Aquestive Therapeutics (AQST) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda scPharmaceuticals (SCPH)|Narxning foydaga va o‘sish sur’atiga nisbati Tectonic Therapeutic Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TNXP (Tonix Pharma)|PEG multiplikatori SXTC|eupraxiapharma.com (EPRX) - Narxning sof foyda o‘sishiga nisbati|BioHarvest Sciences - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EXOZ|Oramed Pharma - PEG multiplikatori|ENTX: Narxning foydaga va o‘sish sur’atiga nisbati|HYFT: PEG multiplikatori|ABVC - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cumberland Pharmaceuticals|O‘sish sur’atiga tuzatilgan narx-foyda quantumbiopharma.com QNTM|Narx-foyda va o‘sish multiplikatori FGEN (FibroGen)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TELO|PEG multiplikatori RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - O‘sish sur’atiga tuzatilgan narx-foyda|Rallybio Corp. - PEG multiplikatori|Lexaria Bioscience (LEXX) - Narx-foyda va o‘sish multiplikatori|PULM: PEG multiplikatori|Pheton Holdings - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori APM|LYRA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Impact BioMedical Inc (IBO)|Narxning foydaga va o‘sish sur’atiga nisbati TNFA (tnfpharma.com)|cbdMD - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati PRFX (PainReform Ltd)|Auris Medical - PEG multiplikatori|LIPO (Lipella Pharma) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|OptiNose, Inc. (OPTN) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori pieris.com|PROC (Procaps) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Petros Pharmaceuticals Inc PTPI|Narxning foydaga va o‘sish sur’atiga nisbati Qilian International Holding Group Limited (QLI)|ACELYRIN Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati TFF Pharmaceuticals TFFP
